Expression of A3 Adenosine Receptors in Human Lymphocytes: Up-Regulation in T Cell Activation

Molecular Pharmacology

Volumn 65, Issue 3, 2004, Pages 711-719

  Gessi, Stefania ^a,b   Varani, Katia ^a,b   Merighi, Stefania ^a,b,c   Cattabriga, Elena ^a,b   Avitabile, Arianna ^a,b   Gavioli, Riccardo ^a   Fortini, Cinzia ^a   Leung, Edward ^c   Mac Lennan, Stephen ^e   Borea, Pier Andrea ^a,b,d  

^a UNIVERSITY OF FERRARA   (Italy)

^b Centro Nazionale di Eccellenza   (Italy)

^c King Pharmaceuticals   (United States)

^d UNIVERSITY OF FERRARA   (Italy)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 FURYL) 5 [3 (4 METHOXYPHENYL)UREIDO] 8 PROPYLPYRAZOLO[4,3 E] 1,2,4 TRIAZOLO[1,5 C]PYRIMIDINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; CD4 ANTIGEN; MRE 3016F20; MRE 3105F20; N6 (3 IODOBENZYL) 2 CHLOROADENOSINE 5' N METHYLURONAMIDE; RADIOLIGAND; TRITIUM; UNCLASSIFIED DRUG; CYCLIC AMP;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; DRUG POTENCY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION; THERMODYNAMICS; WESTERN BLOTTING; BINDING SITE; KINETICS; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; RADIOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UPREGULATION;

BINDING SITES; BINDING, COMPETITIVE; BLOTTING, WESTERN; CYCLIC AMP; HUMANS; KINETICS; LYMPHOCYTE ACTIVATION; RADIOLIGAND ASSAY; RECEPTOR, ADENOSINE A3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; THERMODYNAMICS; UP-REGULATION;

EID: 10744223679     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.65.3.711     Document Type: Article

References (41)

1. Apasov S, Koshiba M, Redegeld F, and Sitkovsky MV (1995) Role of extracellular ATP and P1 and P2 classes of purinergic receptors in T-cell development and cytotoxic T lymphocyte effector functions. Immunol Rev 146:5-19.
2. 3 receptor antagonists. Trends Pharmacol Sci 21:456-459.
3. 3 adenosine receptor antagonists: influence of the chain at the N8 pyrazole nitrogen. J Med Chem 43:4768-4780.
4. Barbieri D, Abbracchio MP, Salvioli S, Monti D, Cossarizza A, Ceruti S, Brambilla R, Cattabeni F, Jacobson KA, and Franceschi C (1998) Apoptosis by 2-chloro-2′-deoxy-adenosine in human peripheral blood mononuclear cells. Neurochem Int 32:493-504.
5. 3 receptors. J Immunol 158:5400-5408.
6. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72:248-254.
7. 3 adenosine receptor. J Leukoc Biol 66:495-501.
8. 3 adenosine receptor. Thromb Haemost 88:123-130.
9. Butler JJ, Mader JS, Watson CL, Zhang H, Blay J, and Hoskin DW (2003) Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways. J Cell Biochem 89:975-991.
10. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
11. 3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. Br J Pharmacol 127:188-194.
12. 3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells. Mol Pharmacol 63:342-350.
13. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, and Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552.
14. 3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study. Mol Pharmacol 61:415-424.
15. 3 adenosine receptors in Jurkat T cells. Br J Pharmacol 134:116-126.
16. 2A adenosine receptors in human peripheral blood cells. Br J Pharmacol 129:2-11.
17. Higuchi R, Fockler C, Dollinger G, and Watson R (1993) Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology 11:1026-1030.
18. Hirschhorn R (1995) Adenosine deaminase deficiency: molecular basis and recent developments. Clin Immunol Immunopathol 76:S219-S227.
19. 3 receptor to prevent the induction of murine anti-CD3-activated killer T cells. Int J Cancer 99:386-395.
20. Klinger M, Freissmuth M, and Nanoff C (2002) Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signaling 14:99-108.
21. 3 adenosine receptors on human eosinophils elevates intracellular calcium. Blood 88:3569-3574.
22. 2A purinergic receptor-mediated signaling in murine T cells. J Biol Chem 272:25881-25889.
23. 2A receptor monoclonal antibodies. Mol Pharmacol 55:614-624.
24. Linden J (2001) Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41:775-787.
25. 3 receptor. Cancer Res 54:3521-3526.
26. Merighi S, Varani K, Gessi S, Cattabriga E, Iannotta V, Ulouglu C, Leung E, and Borea PA (2001) Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. Br J Pharmacol 134:1215-1226.
27. 2B adenosine receptors in human lymphocytes: their role in T cell activation. J Cell Science (Wash DC) 112:491-502.
28. Munson PJ and Rodbard D (1980) Ligand: a versatile computerized approach for the characterization of ligand binding systems. Anal Biochem 107:220-239.
29. 2A adenosine receptors: high-affmity agonist binding to receptor-G protein complexes containing Gβ4. Mol Pharmacol 61:455-462.
30. Ohta A and Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature (Lond) 414:916-920.
31. Panther E, Idzko M, Herouy, Rheinen H, Gebicke-haerter PJ, Mrowietz U, Dichmann S, Norgauer J (2001) Expression and function of adenosine receptors in human dendritic cells. FASEB J 15:1963-1970.
32. Polmar SH (1990) The role of adenosine in the regulation of lymphocytic function, in Role of Adenosine and Adenine Nucleotides in the Biological System (Imai S and Nakazawa M eds) pp. 508-514, Elsevier Science Publishers BV, Amsterdam.
33. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887-16890.
34. 3 adenosine receptors. J Immunol 156:3435-3442.
35. 2A adenosine receptor as a physiological immuno-suppressor and to engineer inflammation in vivo. Biochem Pharmacol 65:493-501.
36. 2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis 180:1550-1560.
37. 2A receptor agonists. Br J Pharmacol 132:1017-1026.
38. 2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes Infect 5:515-526.
39. 2A adenosine receptors in HEK-293 cells. Biochem J 352:203-210.
40. 3H]SCH 58261 binding. Br J Pharmacol 122:386-392.
41. 3 adenosine receptors. Mol Pharmacol 57:968-975.